ALBUQUERQUE, NM USA – Indica Labs, an industry leader in quantitative digital pathology, held a ribbon cutting ceremony at its new facility on Friday, May
Press Release: Indica Labs celebrates opening of new facility in Albuquerque, New Mexico Read More »
Indica Labs invites you to attend our Washington D.C. HALO Quantitative Pathology Lunch & Learn Meeting Tuesday, June 4, 2019 Embassy Suites DC Convention Center
Indica Labs’ Washington, D.C. HALO Quantitative Pathology Lunch & Learn Read More »
29 May 2020 | In this webinar, Ines Nearchou from the University of St. Andrews will discuss the methodology and the results of the study which were recently published in Cancer Immunology Research. By way of introduction, Dr. Kate Lillard Tunstall, CSO at Indica Labs, will highlight briefly some of the HALO image analysis tools which were used in the study.
USA 04/26/2019 – Indica Labs and IONpath announced today that a co-marketing agreement has been established to jointly promote their respective technologies for tissue-based, multiplexed
Indica Labs invites you to attend our Paris Quantitative Pathology and HALO User Group Meeting Tuesday, 21 May 2019Espace Vocation République Paris, France Indica Labs is
Indica Labs’ Paris Quantitative Pathology and HALO User Group Meeting Read More »
24 April 2019 | By helping scientists make data-driven decisions faster and more efficiently, artificial intelligence (AI) is revolutionizing drug discovery and development. Pathology is no exception and the Pathology Sciences team at AstraZeneca in Cambridge UK is leading the charge. Here, neural networks are being deployed to search digital slides for specific tissue classes, features and pathologies that are not easily quantified using traditional image analysis or are too time-consuming for pathologists to quantify by eye.
Indica Labs invites you to attend our Shanghai Quantitative Pathology & AI User Group Meeting 2019 Tuesday, April 16, 2019 Parkyard Hotel Shanghai, China CLICK
Indica Labs’ Shanghai Quantitative Pathology & AI User Group Meeting 2019 Read More »
Both immune profiling and tumor budding significantly correlate with colorectal cancer patient outcome but are traditionally reported independently. This study evaluated the association and interaction
Indica Labs invites you to attend our East Coast Quantitative Pathology & AI User Group Meeting 2019 Thursday, April 11, 2019 Le Méridien Boston Cambridge
Indica Labs’ East Coast Quantitative Pathology & AI User Group Meeting 2019 Read More »
SOUTH SAN FRANCISCO, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ: FLDM) and Indica Labs, Inc., today announced a co-marketing relationship for scalable and
